john reed
This speaker appears at this event:

This speaker’s events are being finalized

John Reed, MD, PhD

  • EVP, Global R&D, Sanofi

Dr. Reed, Executive Vice President, serves as the global head of Pharmaceutical Research & Development for Sanofi, reporting to the CEO and participating as a member of the company’s Executive Committee. Prior to joining Sanofi in May 2018, Dr. Reed served as global head of pharmaceutical research and early development at Roche (Basel, Switzerland) for five years (2013-2018). From 2002 to 2013, Dr. Reed served as CEO of one of the largest independent non-profit biomedical research institutes in the United States (Sanford-Burnham Medical Research Institute) (La Jolla, California) and ran a highly productive laboratory that generated more than 900 research publications, over 130 patents, and that was awarded more than one-hundred research grants and trained over 100 post-doctoral fellows. Dr. Reed served on multiple editorial boards of research journals. He was scientific founder or co-founder of four biotechnology companies.

Dr. Reed also served on the Board of Directors for five publicly traded biopharmaceutical and biotechnology companies and on the governing boards for various non-profit biomedical research organizations. During his academic career, Dr. Reed held faculty appointments at several universities. He is a Fellow of the American Association for the Advancement of Science (AAAS) and a recipient of numerous honors and awards for his accomplishments in biomedical research. Dr. Reed obtained his M.D. (medicine) and Ph.D. (immunology) degrees from University of Pennsylvania in 1986 (graduating Alpha Omega Alpha) and his B.A. degree (chemistry) from University of Virginia in 1980 (graduating Phi Kappa Phi). His post-graduate training included residency in Pathology & Laboratory Medicine at the Hospital of the University of Pennsylvania and a post-doctoral fellowship in Molecular Biology at Wistar Institute (Philadelphia).

Covid-19 Broadcast
May 11, 2020
Live Event
May 10–12, 2021